Alnara Pharmaceuticals Lands $35,000,000 Series B Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dc9d54ff-2b17-49d3-a3f3-44fc8896236b&Preview=1
Date
1/28/2010
Company Name
Alnara Pharmaceuticals
Mailing Address
840 Memorial Drive Cambridge, MA 02139
Company Description
Alnara Pharmaceuticals Inc is a pharmaceutical company developing innovative non-systemic protein therapeutics for the treatment of metabolic and inflammatory diseases.
Website
http://www.alnara.com
Transaction Type
Venture Equity
Transaction Amount
$35,000,000
Transaction Round
Series B
Proceeds Purposes
The money will be needed to complete the application and prepare for the potential commercial introduction of liprotamase, which could hit the U.S. market as early as the fourth quarter of this year.
M&A Terms
Venture Investor
MPM Capital
Venture Investor
Bessemer Venture Partners
Venture Investor
Frazier Healthcare Ventures
Venture Investor
Third Rock Ventures